Doctors consulting

Helping to Reshape NASH Clinical Trials

ELF Test indicated as top-performing biomarker in NIMBLE study

Siemens Healthineers is proud to be recognized in Stage I of the Foundation for the National Institutes of Health (FNIH) Biomarkers Consortium Non-Invasive Biomarkers of Metabolic Liver Disease (NIMBLE) study.

The results of the study were recently presented at The Liver Meeting 2021 and showed that the Enhanced Liver Fibrosis (ELF™) Test performed the best of the five blood biomarkers selected for the study.

View Abstract: Primary Results of the NIMBLE Stage 1-NASH CRN Study of Circulating Biomarkers for Nonalcoholic Steatohepatitis and its Activity and Fibrosis Stage

Find out More

Subscription Button Icon
Be the first to know about our events, training, and news